Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)

This study is not yet open for participant recruitment.

Verified October 2009 by Guangdong General Hospital

Study NCT00997685 Information provided by Guangdong General Hospital

First Received on October 18, 2009. No Changes Posted

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Colorectal Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Capecitabine
Oxaliplatin

More general drug interventions related to this trial

Sponsors listed in this trial